1. Home
  2. QTTB vs TKLF Comparison

QTTB vs TKLF Comparison

Compare QTTB & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTTB
  • TKLF
  • Stock Information
  • Founded
  • QTTB 2015
  • TKLF 2006
  • Country
  • QTTB United States
  • TKLF Japan
  • Employees
  • QTTB N/A
  • TKLF N/A
  • Industry
  • QTTB Biotechnology: Pharmaceutical Preparations
  • TKLF Other Specialty Stores
  • Sector
  • QTTB Health Care
  • TKLF Consumer Discretionary
  • Exchange
  • QTTB Nasdaq
  • TKLF Nasdaq
  • Market Cap
  • QTTB 18.9M
  • TKLF 15.7M
  • IPO Year
  • QTTB N/A
  • TKLF 2022
  • Fundamental
  • Price
  • QTTB $1.97
  • TKLF $3.53
  • Analyst Decision
  • QTTB Hold
  • TKLF
  • Analyst Count
  • QTTB 8
  • TKLF 0
  • Target Price
  • QTTB $24.00
  • TKLF N/A
  • AVG Volume (30 Days)
  • QTTB 227.4K
  • TKLF 3.9K
  • Earning Date
  • QTTB 08-06-2025
  • TKLF 07-10-2025
  • Dividend Yield
  • QTTB N/A
  • TKLF N/A
  • EPS Growth
  • QTTB N/A
  • TKLF N/A
  • EPS
  • QTTB N/A
  • TKLF 1.57
  • Revenue
  • QTTB N/A
  • TKLF $210,119,238.00
  • Revenue This Year
  • QTTB N/A
  • TKLF N/A
  • Revenue Next Year
  • QTTB N/A
  • TKLF N/A
  • P/E Ratio
  • QTTB N/A
  • TKLF $2.25
  • Revenue Growth
  • QTTB N/A
  • TKLF 7.38
  • 52 Week Low
  • QTTB $1.35
  • TKLF $2.20
  • 52 Week High
  • QTTB $53.79
  • TKLF $7.25
  • Technical
  • Relative Strength Index (RSI)
  • QTTB 50.74
  • TKLF 37.87
  • Support Level
  • QTTB $1.57
  • TKLF $3.29
  • Resistance Level
  • QTTB $2.08
  • TKLF $3.94
  • Average True Range (ATR)
  • QTTB 0.22
  • TKLF 0.25
  • MACD
  • QTTB -0.03
  • TKLF -0.03
  • Stochastic Oscillator
  • QTTB 53.04
  • TKLF 37.78

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.

Share on Social Networks: